The first quarter of 2025 was a tough one. The S&P 500 lost 4.6%, and the Nasdaq Composite lost 10.4%. Following the trend, ...

Ten thousand staffers at federal health agencies received pink slips on April 1 in a major overhaul to shrink HHS ...

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 ...

Cities and states fighting a historic measles outbreak find themselves undermined by the Trump administration as they ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in an increasingly complex landscape.

Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...

One NIH staffer described Bhattacharya’s note as a “thank you and can’t wait to work with you email ... in the middle of the massacre.” ...

Kennedy Jr. has cut 1,200 NIH workers and thousands more across other health-focused agencies. Such a drastic reduction is ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

WASHINGTON -- Shortly before he was forced to resign, the nation’s top vaccine regulator says he refused to grant Health ...

The decision had been expected by April 1, but the agency now says it needs more information before moving forward.